Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Patricia S. Andrews CEO of Boston Biomedical Inc., Kazuo Koshiya global head of oncology, and Yasushi Matsuki senior director of DSP Cancer Institute, all effective April 24. Sumitomo Dainippon positions oncology as one of its focus 2 therapeutic areas, and Koshiya, as global head of oncology, will oversee research and development collaboration among the DSP Cancer Institute, Boston Biomedical and Sumitomo Dainippon’s Tolero Pharmaceuticals Inc., of Lehi, Utah.

No Comments